Our gel is a customisable platform for drug delivery created through a patented process. Each gel formulation is uniquely tailored to solve a particular problem and deliver a specific outcome, based on a broad set of therapeutic characteristics. The platform forms a chemically and physically stable matrix capable of holding multiple ingredients, including pharmaceuticals, nutraceuticals, and plant-based compounds.
The gel’s structure and composition makes it easier to consume for people who have difficulty swallowing medications, or generally suffer from dysphagia. Its composition and gel formation also provide additional benefits in delivery and absorption.
Our gel is a customisable platform for drug delivery created through a patented process. Each gel formulation is uniquely tailored to solve a particular problem and deliver a specific outcome, based on a broad set of therapeutic characteristics. The platform forms a chemically and physically stable matrix capable of holding multiple ingredients, including pharmaceuticals, nutraceuticals, and plant-based compounds.
The gel’s structure and composition makes it easier to consume for people who have difficulty swallowing medications, or generally suffer from dysphagia. Its composition and gel formation also provide additional benefits in delivery and absorption.
The Gelteq drug delivery system enhances the therapeutic efficacy of the compound delivered at every stage of ingestion, in both animals and humans; addressing the whole experience - from the moment of ingestion through to final absorption.
The gel formula undergoes sheering that creates new interfaces, providing an extra mechanism to provide an improved taste profile. This in turn has the ability to ensure a better dosing experience and promotes better and more ongoing therapeutic adherence.
Our gel technology can be tailored to trigger a fast-release in the stomach, or to shield the deliverable compounds against stomach acids and degradation, allowing differing release profile across the Gastrointestinal Tract (GIT).
Release rates can be configured based on the API or combination of API's. This provides the potential for an API to be targeted to different sites in the GIT.
Our formulations provide chemically and physically stable homogenous matrices, which reduce surface contact to taste buds, providing a more pleasant mouthfeel.
Our “set” gel flows quickly, with low internal resistance that induces the swallowing reflex, reducing potential choking events and providing easier administration.
Our patented technology can revolutionise the delivery of existing ingredients by integrating them into a gel, including, but not limited to: APIs, Excipients, Lipid Soluble, Vitamins, Minerals, Proteins, Carbohydrates and Herbal Extracts.
We continue to seek opportunities and partners to collaborate with, from all fields of oral delivery application.